Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

APODEV 5 MG/ML SOLUCIÓN PARA PERFUSIÓN EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/APODEV 5 MG/ML SOLUCIÓN PARA PERFUSIÓN EFG

Approved

STANDARD

APODEV 5 MG/ML SOLUCIÓN PARA PERFUSIÓN EFG

Evolan Pharma Ab🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Dec 15, 2022
Approval ID: b342df68221bbb4b
Company: Evolan Pharma Ab
Type: Standard

Approval Details

Approval Id: b342df68221bbb4b
Drug Cima Aemps Name: APODEV 5 MG/ML SOLUCIÓN PARA PERFUSIÓN EFG
Register Number: 88396
Holder Company Name: Evolan Pharma Ab
Marketing Company Name: Vegal Farmaceutica S.L.
Authorization Date: 2022-12-15
Dosage Form: SOLUCIÓN PARA PERFUSIÓN
Dose: 5 mg/ml
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Evolan Pharma Ab

Active Ingredients

APOMORFINA HIDROCLORURO HEMIHIDRATO

5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 15, 2022

Approval ID

b342df68221bbb4b

Type

Standard

Back to CIMA-AEMPS Approvals